Investigation Report on China Tamsulosin Market, 2010-2019

Benign Prostate Hyperplasis (BPH) is prevalent among elderly men, influencing one third of those aged above 50. BPH is a benign histopathological disease characterized by hype…
Reference: 1506188
Price: $2,000.00
Tax included

General

Publisher:
CRI
Geography Covered
China
Publication Date
6/4/2015
Pages
30
Version:
2010
Charts:
30
Language
  • English
  • Chinese
Format
License

Description
Benign Prostate Hyperplasis (BPH) is prevalent among elderly men, influencing one third of those aged above 50. BPH is a benign histopathological disease characterized by hyperplasia of stromal and epithelial cells which results in enlarged prostate and then compressed urethra that makes urination difficult. BPH is treatable with medication and operation. Two main categories of drugs are α1-adrenergic receptor blocker and 5α-reductase inhibitor. The former one can effectively palliate symptoms through relaxing bladder neck and prostate and reducing urethral pressure, but it can’t cure BPH.
Compared with other α1-adrenergic receptor blockers, tamsulosin hydrochloride developed by Yamanouchi enjoys higher selectivity and lower risk of urinary tract infections and therefore is fitter for BPH treatment. Ever since its debut in 1993 in Japan, tamsulosin hydrochloride has been sold in various brands in 64 countries according to Yamanouchi’s authorization to Boehringer Ingelheim.
Prostate drug market is highly concentrated in China. Three kinds of prostate drugs – finasteride, tamsulosin and prostat which occupy over 90% of prostate drug market altogether, reported over 10 million sales in sample hospitals in 2005. Tamsulosin develops rapidly after entering China with annual sales less than CNY 50 million in 2005 rising to CNY 201 million in 2014 and CAGR reaching 16.98% during this period. Tamsulosin enjoys a vast market demand in China and products made by Zhejiang Hailisheng Pharmaceutical Co., Ltd, Jiangsu Heng Rui Medicine Co., Ltd, Astellas Pharma Inc, Yamanouchi Pharmaceutical Co., Ltd and Kunming Jida Pharmaceutical Co., Ltd have taken up a large share of the market.
With the aging of the population in China, the incidence of BPH and its number of cases will keep going up. The market size of tamsulosin in China is expected to keep expanding in the next few years.

Readers can get at least the following information through this report:
-market size of tamsulosin in China
-major manufacturers of tamsulosin in Chinese market and their market share
-retail price of tamsulosin in Chinese market
-market outlook of tamsulosin in China

The author suggests the following groups of people purchase this report:
-manufacturers of prostate drugs
-investors/ research institutions interested in Chinese medicine market
-any interest in Chinese medicine market, please contact CRI for customized survey serviceTable of Contents
1 Related Concepts of Tamsulosin
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Tamsulosin in China
2.1 Patent and Approval Status of Tamsulosin in China
2.2 Major Manufacturers
2.3 Sales Status of Tamsulosin in China

3 Survey on Sales Status of Tamsulosin in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Tamsulosin in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Tamsulosin in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Tamsulosin in Chinese Hospitals in 2014
6.1 Kunming Jida Pharmaceutical Co., Ltd (Trade Name: Jidabente)
6.2 Astellas Pharma China, Inc (Trade Name: Harnal)
6.3 Yamanouchi Pharmaceutical Co., Ltd (Trade Name: Harnal)
6.4 Astellas Pharma Inc (Trade Name: Harnal)
6.5 Jiangsu Heng Rui Medicine Co., Ltd
6.6 Zhejiang Hailisheng Pharmaceutical Co., Ltd (Trade Name: Qi Suo)

7 Major Manufacturers of Tamsulosin in Chinese Market, 2010-2014
7.1 Zhejiang Hailisheng Pharmaceutical Co., Ltd
7.2 Jiangsu Heng Rui Medicine Co., Ltd
7.3 Kunming Jida Pharmaceutical Co., Ltd
7.4 Yamanouchi Pharmaceutical Co., Ltd
7.5 Astellas Pharma Inc

8 Market Outlook of Tamsulosin in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

Selected Charts
Chart Patent Status of Tamsulosin in China
Chart Approval Status of Tamsulosin in China
Chart Sales Status of Tamsulosin in China, 2010-2014
Chart Sales Value of Tamsulosin in China, 2010-2014
Chart Sales Value of Tamsulosin in Some Regions in China, 2010-2014
Chart Sales Volume of Tamsulosin in China, 2010-2014
Chart Sales Volume of Tamsulosin in Some Regions in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Tamsulosin for Sales Value, 2010-2014
Chart Sales Value and Market Share of Tamsulosin Made by Astellas, 2010-2014
Chart Sales Value and Market Share of Tamsulosin Made by Kunming Jida, 2010-2014
Chart Sales Value and Market Share of Tamsulosin Made by Zhejiang Hailisheng, 2010-2014
Chart Sales Value and Market Share of Tamsulosin Made by Yamanouchi, 2010-2014
Chart Sales Value and Market Share of Tamsulosin Tablets in China, 2010-2014
Chart Price of Tamsulosin Made by Kunming Jida Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Tamsulosin Made by Astellas Pharma China, Inc in Some Chinese Cities in 2014
Chart Price of Tamsulosin Made by Yamanouchi Pharmaceutical Co., Ltd (Japan) in Some Chinese Cities in 2014
Chart Price of Tamsulosin Made by Astellas Pharma Inc (JA) in Some Chinese Cities in 2014
Chart Price of Tamsulosin Made by Jiangsu Heng Rui Medicine Co., Ltd in Some Chinese Cities in 2014
Chart Price of Tamsulosin Made by Zhejiang Hailisheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Scroll